Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 7OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Pancreatic Neoplasms 1Locally Advanced Cervical Cancer 1Colonic Neoplasms 1

Interventions

Leucovorin 4Fluorouracil 3Oxaliplatin 2Laparoscopy 2Cetuximab 2Capecitabine 2tislelizumab 1ferric maltol 1envafolimab 1Tranexamic Acid 1Surgical Procedures, Operative 1Ropivacaine 1Propofol 1Preoperative Exercise 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Nitrous Oxide 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Motivational Interviewing 1Isoflurane 1Irinotecan 1Ipilimumab 1Immunohistochemistry 1HMPL-013 1Folfox protocol 1Filgrastim 1Fentanyl 1Epinephrine 1Endoscopic Mucosal Resection 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Colonic Neoplasms × Curcumin × Clear all
NCT00295035 2006-02-22

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Tel-Aviv Sourasky Medical Center

Phase 3 Unknown
100 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡